Evogene Ltd. - Ordinary Shares (EVGN) News
Filter EVGN News Items
EVGN News Results
|Loading, please wait...|
EVGN News Highlights
- EVGN's 30 day story count now stands at 10.
- Over the past 16 days, the trend for EVGN's stories per day has been choppy and unclear. It has oscillated between 1 and 5.
- GM are the most mentioned tickers in articles about EVGN.
Latest EVGN News From Around the Web
Below are the latest news stories about Evogene Ltd that investors may wish to consider to help them evaluate EVGN as an investment opportunity.
Medical-grade cannabis developer Canonic Ltd. , and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN ), announced that professor Itamar Grotto will be joining its board of directors . Grotto, f ormer associate director general at the Israeli ministry of health , was responsible for the medicalization reform of cannabis in Israel and oversaw the Israeli medical cannabis agency . He was also the director of Israel''s public health services and a member of the executive board of the WHO , on behalf of the state of … Full story available on Benzinga.com
Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that Professor Itamar Grotto will be joining its Board of Directors. Professor Grotto, former Associate Director General at the Israeli Ministry of Health, was responsible for the medicalization reform of Cannabis in Israel and oversaw the Israeli Medical Cannabis Agency. He was also the Director of Israel's Public Health Services
Computational biology company Evogene Ltd . (NASDAQ: EVGN ) will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022 . On the day of the announcement, the company''s management will host a conference call to discuss the results at 09:00 a.m. EST. Evogene established three unique … Full story available on Benzinga.com
Evogene Financial Results and Earnings Announcement Schedule for the Full Year and Fourth Quarter of 2021
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the full year and fourth quarter of 2021 on Thursday, March 10, 2022.
Evogene Ltd. (NASDAQ-GM: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments announced today that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern. The conference will span three days, starting on February 23rd until February 25th from 8:30AM until 5PM EST.
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has shipped a first batch of its unique cannabis varieties to Portugal, following receiving approval to export from the Israeli Ministry of Health and Ministry of Agriculture.
In this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market. […]
Evogene to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference from January 25-27th, 2022
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today it is participating in Edison Group's Open House Event, scheduled to take place virtually this month.
Canonic Announces Positive Results in Pre-Clinical Studies in its Precise Product Program for Medical Cannabis
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive results in pre-clinical studies in inflammatory and pain model systems conducted in Israel by Hadassah Medical Center in Jerusalem and by Migal - Galilee Research Institute in Kiryat Shmona. The results support the identification of specific cannabis varieties with heightened anti-inflammatory and pain relief properties fo